TriVerity™ by Inflammatix delivers rapid immune-response insights to support ED clinical assessment and risk stratification with patients suspected of infection
San Francisco Bay Area
Joined February 2017
- Tweets701
- Following117
- Followers1K
- Likes302
New @BARDA funding: Project Compass will test whether #TriVerity can help identify which patients with severe infection are likely to benefit from corticosteroids, and which may be harmed: inflammatix.com/inflammatix-…
We’re honored to be selected as the commercialization collaborator and bedside platform developer for a @StanfordMed-led team as part of @ARPA_H’s CIRCLE program.
Read the full release: inflammatix.com/inflammatix-…
We're heading to #ACEP26 in Chicago! Visit booth #2723, Oct 5-8, to see how #TriVerity helps ED clinicians win the first decision.
And watch a presentation on new findings on TriVerity in adult ED patients w/ suspected acute infection — Oct 7, 8:21am.
We're proud to sponsor @SepsisAlliance Summit — our CEO @TimSweeney83 speaks 9/17, 1:50 pm ET, on moving past syndromic uncertainty toward a new approach to identify infection type and risk stratify patients..
Register FREE: SepsisSummit.org
New data: in 467 ED patients with suspected infection — including co-infections & immunocompromise — #TriVerity showed high specificity & sensitivity for bacterial & viral infection.
link.springer.com/article/10…
Excited to see USA Health University Hospital featured in @Fox10News as the first hospital in Alabama to implement TriVerity® in its ED — helping clinicians catch sepsis earlier with a single 30-minute blood test.
fox10tv.com/2026/07/08/healt…
NEXT WEEK! Join us Monday, June 29 at 12 PM ET as Dr. Edward Panacek from USA Health shares how TriVerity® is helping his ED make faster, more confident disposition decisions for acute infection patients.
Save your spot: hmacademy.zoom.us/meeting/re…
We're proud to be collaborating with @UNMC and the National Quarantine Unit to support the hantavirus outbreak response using #TriVerity — part of a broader shift toward real-time immune response over pathogen confirmation. Read more:
inflammatix.com/hantavirus-o…
"All we have left is prayer."
A doctor said that to our CEO @TimSweeney83 in training, watching a young patient die of sepsis with no drug to give him.
20 years later, he's changing that. The story, with Sharon Kedar 🎧
innovateandelevatepodcast.co…
Join us Monday, June 29 at 12 PM ET with Dr. Edward Panacek (USA Health) and Lukas Chandler (@TheHMAcademy) to learn how TriVerity® transformed ED triage and disposition for acute infection patients.
🔗 Register: hmacademy.zoom.us/meeting/re…
#TriVerity #FOAMed #MedTwitter
Tomorrow: Dr. Rothman (Johns Hopkins), Dr. Panacek (USA Health), and Dr. Sweeney (Inflammatix) go live on the future of infection diagnostics in the ED.
Free, 3 PM ET.
Sign up: us02web.zoom.us/webinar/regi…
What is it and how sick is the patient?
These questions drive uncertainty and ED bottlenecks.
Watch our webinar w/ @QIAGEN & @BDandCo — Dr. @TimSweeney83 explains how TriVerity answers both questions in ~30 min for earlier, more confident disposition.
labroots.com/ms/webinar/rna-…
Live on April 28 at 3 PM ET: faculty from Johns Hopkins, USA Health, and Inflammatix on why ED diagnostic tools need to evolve and what host-response means for clinical decisions.
Free with live Q&A.
Register: us02web.zoom.us/webinar/regi…
There’s still time to register!
Learn how immune-response insights from #TriVerity can augment clinical judgment and support earlier infection and disposition decisions in the ED.
Save your spot now:
labroots.com/ms/webinar/rna-…
#MedTwitter #FOAMed
APRIL 8 | Join our CEO Dr. @TimSweeney83 and Dr. Kalle Guenther (PreAnalytiX) for a free webinar on how immune-response insights from #TriVerity can support earlier infection and disposition decisions in the ED.
Register: labroots.com/ms/webinar/rna-…
#MedTwitter #FOAMed
In a new Q&A with @StanfordMed Magazine, our co-founder Dr. @PurveshKhatri explains why reading the body's immune response — not hunting for a single pathogen — is the key to faster, smarter ER decisions.
Read more: stanmed.stanford.edu/rapid-s…
#MedEd #EmergencyMedicine #Sepsis
APRIL 8 | Join our CEO Dr. @TimSweeney83 and Dr. Kalle Guenther (PreAnalytiX) for a free webinar on how immune-response insights from #TriVerity can support earlier infection and disposition decisions in the ED.
Register: labroots.com/ms/webinar/rna-…
#MedTwitter #FOAMed
Inflammatix retweeted
We’re the 1st health system in SC to provide the TriVerity immune response test, new diagnostic technology from @Inflammatix_Inc that supports earlier, more confident decision-making with suspected acute infection or sepsis.
anmed.org/about/news-media/n…
#BetterStartsHere
Big milestone out of South Carolina — @AnMed_Health is now the first health system in the Carolinas to bring #TriVerity to its emergency department.
Read more: anmed.org/about/news-media/n…
#MedTwitter #PrecisionMedicine
ANNOUNCEMENT: Our CEO and co-founder @TimSweeney83 has joined the @SepsisAlliance Board of Directors, bringing 20+ years of experience in sepsis care, diagnostics, and health policy.
Read the release: sepsis.org/news/tim-sweeney-…
#MedTwitter #Sepsis
“In the past, we really have not had a good diagnostic test for sepsis. That now has changed.”
Dr. Edward Panacek of @usaunivhospital shares how #TriVerity is enabling earlier, more accurate disposition of patients with suspected acute infection & sepsis.
wkrg.com/health-2/new-test-t…
